CureVac Appoints Malte Greune As COO

(RTTNews) - CureVac N.V. (CVAC) said that it has appointed Malte Greune as Chief Operating Officer effective July 1, 2021.

Greune joins CureVac from Sanofi-Aventis Deutschland GmbH where he held various management positions for almost ten years. Prior to his position as Head of Diabetes, Oncology and Devices at Sanofi, he worked as Senior Vice President of Animal Health Manufacturing for the Merck Manufacturing Division, USA, where he led an international network of 28 sites - including 18 integrated vaccine sites.

CureVac also announced that Florian von der Mülbe, co-founder and Chief Production Officer, will now focus his extensive production expertise exclusively on the expansion and accelerated development of The RNA Printer, CureVac's solution for mobile, autonomous and fully automated manufacturing of GMP-grade RNA vaccines and therapeutics.

von der Mülbe will resign from the Management Board of CureVac N.V. Greune will assume von der Mülbe's position on the Management Board.